Media & Press Updates
What’s Happening
News
-
April 5, 2024 - OniX AI: Revolutionizing Pipeline Analysis and Project Discovery – Partner with Us!- see T1D examples below
OniX is actively seeking partners to advance the development of its OniX AI, which not only conducts comprehensive pipeline analysis but also serves as a powerful tool for discovering new and innovative projects in the vast research landscape. Our overarching objective involves revolutionizing pipeline analysis and project discovery, empowering our partners to unlock insights and drive innovation. Furthermore, we aspire to integrate this functionality within the OniX hub, empowering our partners to generate analyses for any disease, target, or technology at their convenience.
T1D Preclinical - T1D Clinical - T1D Biotech/Startup pipelines
A comprehensive overview of patient engagement in biotech and pharmaceutical companies, emphasizing both traditional methods and innovative approaches.
-
March 28,2024- Unveiling Parkinson's Disease:A Glimpse into Ongoing Research with OniX AI
Parkinson's disease (PD) is a neurodegenerative disorder affecting millions globally. While the exact cause remains elusive, significant research efforts are underway to unravel the mechanisms behind PD and identify potential therapeutic targets. OniX AI, coupled with the OniX Hub, offers a powerful tool to navigate the vast amount of research data and pinpoint promising avenues for exploration. Let's delve into a few examples of ongoing PD research highlighted by OniX AI, showcasing its ability to identify trends and potential breakthroughs.
OniX AI, a powerful tool within the OniX Hub, is designed to be your intelligent partner on the ever-evolving frontier of scientific discovery. It seamlessly processes and analyzes vast amounts of data, including research grants, publications, clinical trials, and patents. This summary offers a glimpse into the potential of OniX AI, using curated examples of Alzheimer's disease research grants.
-
March 25, 2024 - Facilitating Partnerships, Patient Engagement and Access to Key Opinion Leaders with OniX AI and OniX Hub
Partnerships and engagement are essential cornerstones of the research enterprise, propelling innovation and progress. With the assistance of OniX Hub and OniX AI, the tasks of identifying partners, accessing Key Opinion Leaders (KOLs), and developing patient-centric therapeutics are made more accessible. By harnessing the power of data and AI, researchers and companies can navigate collaborations with confidence, accelerating the pace of discovery and ultimately improving patient outcomes.
-
March 25, 2024 _ 🔬 Exciting Update from OniX AI! 🔍
-
March 21, 2024 - UNVEILING INNOVATION: A deep dive into OniX AI and OniX Hub
-
Example Network Graph to develop a landscape analysis and to find innovate projects related to Obesity
-
TIGIT: The ability of OniX AI to track the evolution of research areas by number of grants awarded over time, showcasing emerging trends and potential breakthroughs
-
University of Rochester, NY, USA: Researchers at the University Rochester are developing an Anti-Fouling Peptide-Nanoparticle Conjugates for the Delivery of siRNA to Fractures
-
Example of Japanese Biotech Progress: Transition of Heartseed from Academia (Keio University) to Biotech Company
-
-
March 11 2024 - Unlocking Intelligence for Tomorrow's Therapeutics: The Power of OniX Hub and OniX AI
Biotech startups naturally accumulate competitive intelligence (CI) through various informal channels, such as attending conferences, interacting with industry peers, or reading market reports. Unfortunately, the challenge lies in the lack of organized management of this information, hindering the firm from fully optimizing these valuable resources and maximizing their potential value.
OniX demonstrates its AI capabilities by providing a preclinical and clinical landscape analysis of two rare skin diseases: Blau Syndrome and Hidradenitis suppurativa
-
April 21, 2021 - National Cancer Institute (NCI) technologies added to OniX
-
September 9, 2020 - Asahi Kasei Pharma Corporation Joins OniX: Partnerships to accelerate research in Pain Management, Neurodegenerative Diseases, Autoimmune Diseases, Critical Care and Refractory Muscle Diseases
-
September 1, 2020: OniX and Skipper Bio Med Partner to advance Lung and Pancreatic Cancer research
-
October 29, 2019: THE OniX - ALTUM Competitive Advantage: Transform the grants, prizes and challenges experience
-
October 22, 2019: OniX partners with Altum to accelerate research:Grants|Prizes|Challenges Initiative
-
October 14, 2019: OniX: New Startup Changing The Game
OniX Virtual Travels
-
AACR 2024, San Diego, California, April 5-10, 2024
-
Bio International, San Diego, California, June 3-6, 2024
-
Bio Japan, Pacifico Yokohama, October 9-11
-
BioFit, Lilly, France, Dec 3-4, 11-12